Sign In
The CEO Views Small logos
  • Home
  • Technology
    Artificial Intelligence
    Big Data
    Block Chain
    BYOD
    Cloud
    Cyber Security
    Data Center
    Digital Transformation
    Enterprise Mobility
    Enterprise Software
    IOT
    IT Services
    Innovation
  • Platforms
    How IBM Maximo Is Revolutionizing Asset Management
    How IBM Maximo Is Revolutionizing Asset Management
    IBM
    7 Min Read
    Optimizing Resources: Oracle DBA Support Services for Efficient Database Management
    Oracle
    Oracle
    9 Min Read
    The New Google Algorithm Update for 2021
    google algorithm update 2021
    Google
    5 Min Read
    Oracle Cloud Platform Now Validated for India Stack
    Service Partner Horizontal
    Oracle
    3 Min Read
    Oracle and AT&T Enter into Strategic Agreement
    oracle
    Oracle
    3 Min Read
    Check out more:
    • Google
    • HP
    • IBM
    • Oracle
  • Industry
    Banking & Insurance
    Biotech
    Construction
    Education
    Financial Services
    Healthcare
    Manufacturing
    Mining
    Public Sector
    Retail
    Telecom
    Utilities
    Gaming
    Legal
  • Functions
    RISMA Systems: A Comprehensive Approach to Governance, Risk and Compliance
    Risma Systems
    ENTREPRENEUR VIEWSGDPR
    9 Min Read
    Happiest Minds: A “Privacy by Design” approach is key to creating GDPR compliant businesses
    Happiest Minds 1
    GDPR
    8 Min Read
    Gemserv: GDPR 2020 and Beyond
    Gemserv 1
    GDPR
    9 Min Read
    ECCENCA:GDPR IS STILL AN UNTAMED ANIMAL
    eccenca 1
    GDPR
    6 Min Read
    Boldon James: HOW ENTERPRISES CAN MITIGATE THE GROWING THREATS OF DATA
    Boldon James 1
    GDPR
    8 Min Read
    Check out more:
    • GDPR
  • Magazines
  • Entrepreneurs Views
  • Editor’s Bucket
  • Press Release
  • Micro Blog
  • Events
Reading: Vivera: Revolutionizing Patient Care With Innovative Patented Technology
Share
The CEO Views
Aa
  • Home
  • Magazines
  • Enterpreneurs Views
  • Editor’s Bucket
  • Press Release
  • Micro Blog
Search
  • World’s Best Magazines
  • Technology
    • Artificial Intelligence
    • Big Data
    • Block Chain
    • BYOD
    • Cloud
    • Cyber Security
    • Data Center
    • Digital Transformation
    • Enterprise Mobility
    • Enterprise Software
    • IOT
    • IT Services
  • Platforms
    • Google
    • HP
    • IBM
    • Oracle
  • Industry
    • Banking & Insurance
    • Biotech
    • Construction
    • Education
    • Financial Services
    • Healthcare
    • Manufacturing
    • Mining
    • Public Sector
    • Retail
    • Telecom
    • Utilities
  • Functions
    • GDPR
  • Magazines
  • Editor’s Bucket
  • Press Release
  • Micro Blog
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
The CEO Views > Blog > Magazine > ENTREPRENEUR VIEWS > Vivera: Revolutionizing Patient Care With Innovative Patented Technology
ENTREPRENEUR VIEWS

Vivera: Revolutionizing Patient Care With Innovative Patented Technology

The CEO Views
Last updated: 2024/02/07 at 4:00 AM
The CEO Views
Share
viveraaa
viveraaa

Revolutionizing Patient Care with Innovative Patented Technology 

Prescription drug misuse is a critical health crisis. Misusing medications, even those prescribed, can lead to severe health complications, notably addiction. This is where Vivera steps in. 

Innovation for Safety and Compliance 

Vivera is a leader in healthcare, harnessing state–of–the–art technologies. 

Its goal? 

Strengthen medication safety and compliance, thereby reducing prescription drug abuse and streamlining communication throughout the medication supply chain. 

Vivera’s Story of Inception 

Vivera’s inception is deeply personal. Paul Edalat, the Company’s Chairman, Founder, and CEO, started as a health enthusiast passionate about tennis and fitness.

He leveraged his experiences and entrepreneurial skills to make a mark in the rapidly growing fitness and wellness sectors. 

While his love for athletics and fitness never waned, a personal tragedy shifted his priorities. In 2004, his brother Peter was diagnosed with an aggressive form of Hodgkin’s lymphoma. Supporting him throughout his two–year battle with cancer, Mr. Edalat was exposed to numerous flaws within the healthcare system. 

One of the most glaring issues was the lack of safety protocols around prescribing medications. Peter was prescribed high doses of opioids to manage his chemotherapy pain. But the absence of safeguards led him to become addicted. 

This painful experience, combined with his profound knowledge and expertise in health and wellness, ignited a determination within Mr. Edalat to create a company that genuinely prioritized people over profit. He recognized the need for a safer and more efficient method of prescribing and dispensing medications, so he founded Vivera. 

Under Mr. Edalat’s leadership, Vivera has scaled to new heights, introducing two revolutionary products: TABMELT for biopharmaceutical delivery and ZICOH, a smart, dose–controlled prescription medication delivery device. 

Highlighting ZICOH for Smart Drug Delivery 

ZICOH was designed to address the challenges associated with patient adherence. It is a patented, dose–controlled, smart medication delivery device that ZICOH works by dispensing precise medication doses only to the registered patient, leaving little room for misuse or diversion. The timing feature supports adherence by restricting access to off–schedule doses. 

ZICOH integrates seamlessly with ZICOH ConnectTM, a synchronized, cloud–based software system with strong data organization and Al capabilities. They collect and aggregate real–time prescribing data and generate actionable insights to facilitate medication adherence, oversight, and compliance. 

Ultimately, the ZICOH medication delivery system aims to provide the targeted release of medications and may offer a solution to better control medications known to be highly addictive and highly abused. 

Vivera’s Patient–First Philosophy 

Since day one, Vivera has been committed to serving underrepresented communities, consistently placing patients at the forefront. The Company’s journey began with unique medication delivery solutions. It has expanded into various divisions, all united in elevating patient care. 

Vivera Technologies and Vivera Medical Devices are dedicated to creating cutting–edge technologies to revolutionize patient care. 

Vivera BioSciences focuses on developing medications for various conditions using its patented and patent–pending TABMELT technology for sublingual drug delivery. 

Vivera Neurosciences is dedicated to investigating and developing therapies for disorders of the central nervous system, including psychiatric, neurological, and fluency disorders, to enhance patients‘ lives and offer better options for healthcare professionals. 

Vivera Advanced Diagnostics uses its Lab Information Management System (LIMS), LabPort, to deliver patients quick and reliable diagnostic and wellness test results.

The future is technology-driven. Al, machine learning, and big data are reshaping drug discovery and patient care. 

The Pros and Cons of Technology 

Advanced technologies such as artificial intelligence (AI), machine learning (ML), and big data analytics have transformed drug discovery. By leveraging these technologies, healthcare professionals can identify new drug targets, predict the efficacy and safety of novel compounds, and accelerate the drug discovery process.

Technology is transforming the way drugs are delivered to patients. Digital health technologies such as telemedicine, remote monitoring, and mobile health apps enable patients to receive personalized care and manage their health from the comfort of their homes. 

Although technology can positively transform the industry, there are potential drawbacks to consider. While using Al and big data to inform drug development, there remains a risk of perpetuating biases and inequalities in healthcare, particularly if they aren’t properly calibrated and validated. Digital health technologies also raise concerns about data privacy and security. 

Vivera considers technology’s benefits and potential draw-backs with each project it undertakes. 

Mr. Edalat says, “The future is technology–driven. Al, machine learning, and big data are reshaping drug discovery and patient care, offering more personalized and efficient healthcare solutions. Yet, we’re mindful of the challenges, particularly in maintaining data privacy and avoiding biases in Al.” 

Commitment to Innovation and Continuous Research 

Vivera is committed to innovation and continuous research to develop groundbreaking products that address unmet medical needs across the spectrum. They have invested in a talented team of researchers, scientists, and professionals who share the vision for improving patients‘ lives worldwide. 

Backed by a team of highly skilled researchers and highly talented developers, Vivera uses a unique approach to a multidisciplinary methodology that integrates hardware, software, security, firmware, networking, communicating, learning, and tracking at the system level. 

Innovations at Vivera begin with identifying real–world problems relating to patient care and a healthy society. 

Looking Forward 

Mr. Edalat’s vision is clear. He plans to revolutionize drug delivery and enhance patient safety. “Quality care should be accessible to everyone,” he says. 

His advice to future healthcare leaders? 

Prioritize patient well-being, seek mentorship, build diverse relationships, and stay ahead of healthcare technology trends.

The CEO Views December 22, 2023
Share this Article
Facebook Twitter LinkedIn Email Copy Link
Previous Article flow FlowPatterns/ESS: Empowering Service Providers with Comprehensive Digital Roadmap
Next Article space Space Plane Corporation: Making Orbital Space Tourism A Spectacular Experience
Understanding the Dynamics of Senior Care

Understanding the Dynamics of Senior Care: Trends, Challenges and Innovations

April 15, 2025
Virtual CTO as a Startups Best Friend
Micro Blog

Virtual CTO as a Startup’s Best Friend During Challenging Periods

The CEO Views By The CEO Views August 20, 2024
What Trading Styles Are Best Suited for High Funding Prop Firm Programs
Financial Services

What Trading Styles Are Best Suited for High-Funding Prop Firm Programs?

The CEO Views By The CEO Views April 30, 2025
Matt Williamson Board Member CEO 1
ENTREPRENEUR VIEWS

Founders Trust and the Long Term View: Redefining Success without Consolidation

The CEO Views By The CEO Views April 2, 2024
The Top Ten Approaches to Achieve Cloud Security
Cloud

The Top Ten Approaches to Achieve Cloud Security

The CEO Views By The CEO Views March 7, 2024

Ontario’s thriving iGaming scene: The biggest red flags signalling you should change your online casino operator

June 3, 2025

How MentorCity’s Cloud-Based Mentoring Software Helps People and Businesses Grow and Succeed

June 3, 2025

Super Bowl or NFL: The Inevitable Impact of American Football Leagues on the Sports Apparel Industry

June 3, 2025

Social Media API: Unlocking the Power of Real-Time Online Data

June 3, 2025

You Might Also Like

Mike Akard
ENTREPRENEUR VIEWS

A Legacy of Innovation and Excellence

14 Min Read
Nathan Udy, President & CEO
ENTREPRENEUR VIEWS

Nathan Udy: A Visionary Leader Rebuilding the Benefits System

8 Min Read
Jason Lau, CEO
ENTREPRENEUR VIEWS

Jason Lau: Leading with Problem-solving, Adaptability, and Commitment to Long-term Success

8 Min Read
Dr.Che Jordan, CEO
ENTREPRENEUR VIEWS

Dr.Che Jordan: Leading with Compassion to Transform Lives

7 Min Read
Small logos Small logos

© 2025 All rights reserved. The CEO Views

  • About Us
  • Privacy Policy
  • Advertise with us
  • Reprints and Permissions
  • Business Magazines
  • Contact
Reading: Vivera: Revolutionizing Patient Care With Innovative Patented Technology
Share

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?